News

Filter

Current filters:

Finland

In 2014, Finland’s pharma market saw steady development

16-02-2015

Last year, the pharmacy and hospital sectors of the Finnish pharmaceutical market grew relatively steadily,…

FinlandMarkets & MarketingPharmaceuticalPricing

Biotie receives final European milestone from Lundbeck on Selincro French launch

Biotie receives final European milestone from Lundbeck on Selincro French launch

19-09-2014

Danish CNS drug specialist Lundbeck has brought Selincro (nalmefene) on the market in France. Selincro,…

BiotechnologyBiotie TherapiesFinlandFranceLicensingLundbeckNeurologicalSelincro

Finland’s medicines wholesale prices continue to decrease

Finland’s medicines wholesale prices continue to decrease

05-05-2014

In 2013, the wholesale prices of medicines dispensed by pharmacies in Finland dropped markedly (- 2.5%).…

FinlandNorthern EuropePharmaceuticalPricing

Biotie invests in Alzheimer’s drug SYN120 as it drops epilepsy pathway

Biotie invests in Alzheimer’s drug SYN120 as it drops epilepsy pathway

11-03-2014

Finland-based Biotie Therapies (Nasdaq OMX: BTH1V), which is focused on neurodegenerative and psychiatric…

BiotechnologyBiotie TherapiesFinancialFinlandHealthcareNeurologicalNRL-1SYN120

Orion licenses Janssen to develop novel treatment for Alzheimer's disease

Orion licenses Janssen to develop novel treatment for Alzheimer's disease

20-12-2013

Orion Corp has entered into a license agreement with Janssen Pharmaceuticals for the development and…

FinlandJanssenLicensingNeurologicalNorthern EuropeOrion CorpPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top